Tissue Engineering & Regenerative Medicine

Tissue engineering and regenerative medicine aim to repair, replace, or regenerate damaged tissues and organs using biomaterials, cells, and bioactive molecules. Scaffold-based constructs, 3D bioprinting, and hydrogel technologies provide structural support and promote cell growth, differentiation, and tissue organization. Integration of stem cells, growth factors, and gene therapy enhances regenerative potential and functionality. Applications include cardiac tissue repair, skin regeneration, musculoskeletal reconstruction, and organoid development for disease modeling. Advanced bioreactors and dynamic culture systems improve tissue maturation and scalability for clinical translation. Ethical, safety, and regulatory considerations guide responsible implementation in human therapies. Preclinical and clinical studies demonstrate promising outcomes in wound healing, organ replacement, and degenerative disease management. Interdisciplinary collaboration between biologists, engineers, and clinicians drives innovation and accelerates translation from bench to bedside. Tissue engineering and regenerative medicine are redefining the limits of medical treatment by offering sustainable, patient-specific, and functionally integrated solutions that restore health and improve quality of life.

    Related Conference of Tissue Engineering & Regenerative Medicine

    December 11-12, 2025

    7th International Conference on Biochemistry

    Prague, Czech Republic
    December 22-23, 2025

    29th World Congress on Biotechnology

    Barcelona, Spain
    March 23-24, 2026

    29th European Biotechnology Congress

    Rome, Italy
    April 27-28, 2026

    32nd Asia Pacific Biotechnology Congress

    Dubai, UAE
    August 27-28, 2026

    30th Global Congress on Biotechnology

    Berlin, Germany

    Tissue Engineering & Regenerative Medicine Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in